Evidence-Based Complementary Medicine in Breast Cancer Therapy
Identifieur interne : 004776 ( Pmc/Corpus ); précédent : 004775; suivant : 004777Evidence-Based Complementary Medicine in Breast Cancer Therapy
Auteurs : Josef BeuthSource :
- Breast Care [ 1661-3791 ] ; 2009.
Abstract
Complementary medicine is currently widely debated by the oncologic community, because the required scientific proof of safety and effectiveness for most of the therapeutic approaches ha s not yet been met with definite results. In the past years, basic research and clinical evaluation of defined complementary therapeutic concepts in oncology have been intensified in an attempt to integrate these procedures into evidence-based medicine. According to definition, scientifically-based therapies of complementary medicine cannot replace the well-studied conventional cancer-destructive therapies such as surgery, chemotherapy, radiotherapy, or hormone therapy. Complementary approaches in oncology that are recommended as an addition to standard cancer-destructive therapies claim to optimize this therapy. A great body of data emerging from scientifically sound clinical trials prove that defined complementary procedures are beneficial for the patients.
Url:
DOI: 10.1159/000194306
PubMed: 20877679
PubMed Central: 2942012
Links to Exploration step
PMC:2942012Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evidence-Based Complementary Medicine in Breast Cancer Therapy</title><author><name sortKey="Beuth, Josef" sort="Beuth, Josef" uniqKey="Beuth J" first="Josef" last="Beuth">Josef Beuth</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20877679</idno><idno type="pmc">2942012</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2942012</idno><idno type="RBID">PMC:2942012</idno><idno type="doi">10.1159/000194306</idno><date when="2009">2009</date><idno type="wicri:Area/Pmc/Corpus">004776</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004776</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Evidence-Based Complementary Medicine in Breast Cancer Therapy</title><author><name sortKey="Beuth, Josef" sort="Beuth, Josef" uniqKey="Beuth J" first="Josef" last="Beuth">Josef Beuth</name></author></analytic><series><title level="j">Breast Care</title><idno type="ISSN">1661-3791</idno><idno type="eISSN">1661-3805</idno><imprint><date when="2009">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Summary</title><p>Complementary medicine is currently widely debated by the oncologic community, because the required scientific proof of safety and effectiveness for most of the therapeutic approaches ha s not yet been met with definite results. In the past years, basic research and clinical evaluation of defined complementary therapeutic concepts in oncology have been intensified in an attempt to integrate these procedures into evidence-based medicine. According to definition, scientifically-based therapies of complementary medicine cannot replace the well-studied conventional cancer-destructive therapies such as surgery, chemotherapy, radiotherapy, or hormone therapy. Complementary approaches in oncology that are recommended as an addition to standard cancer-destructive therapies claim to optimize this therapy. A great body of data emerging from scientifically sound clinical trials prove that defined complementary procedures are beneficial for the patients.</p></div></front></TEI><pmc article-type="review-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Breast Care (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Breast Care (Basel)</journal-id><journal-id journal-id-type="publisher-id">BRC</journal-id><journal-title-group><journal-title>Breast Care</journal-title></journal-title-group><issn pub-type="ppub">1661-3791</issn><issn pub-type="epub">1661-3805</issn><publisher><publisher-name>S. Karger GmbH</publisher-name><publisher-loc>Lörracherstrasse 16 a, P.O. Box · Postfach · Case postale, D–79095, Freiburg, Germany · Deutschland · Allemagne, Phone: +49 761 45 20 70, Fax: +49 761 4 52 07 14, information@karger.de</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20877679</article-id><article-id pub-id-type="pmc">2942012</article-id><article-id pub-id-type="doi">10.1159/000194306</article-id><article-id pub-id-type="publisher-id">brc0004-0008</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article · Übersichtsarbeit</subject></subj-group></article-categories><title-group><article-title>Evidence-Based Complementary Medicine in Breast Cancer Therapy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Beuth</surname><given-names>Josef</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff>Institute for Naturopathy, University of Cologne, Germany</aff><author-notes><corresp id="cor1">*Prof. Dr. med. Josef Beuth, Institut zur wissenschaftlichen Evaluation naturheilkundlicher Verfahren, an der Universität zu Köln, Joseph-Stelzmann-Str. 9//Gebäude 35a, 50931 Köln, Germany, Tel. +49 221478-6414, Fax -7017, <email>hans.beuth@uk-koeln.de</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>20</day><month>2</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>2</month><year>2010</year></pub-date><pmc-comment> PMC Release delay is 12 months and 0 days and was based on the
<volume>4</volume><issue>1</issue><fpage>8</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright © 2009 by S. Karger GmbH, Freiburg</copyright-statement><copyright-year>2009</copyright-year></permissions><abstract><title>Summary</title><p>Complementary medicine is currently widely debated by the oncologic community, because the required scientific proof of safety and effectiveness for most of the therapeutic approaches ha s not yet been met with definite results. In the past years, basic research and clinical evaluation of defined complementary therapeutic concepts in oncology have been intensified in an attempt to integrate these procedures into evidence-based medicine. According to definition, scientifically-based therapies of complementary medicine cannot replace the well-studied conventional cancer-destructive therapies such as surgery, chemotherapy, radiotherapy, or hormone therapy. Complementary approaches in oncology that are recommended as an addition to standard cancer-destructive therapies claim to optimize this therapy. A great body of data emerging from scientifically sound clinical trials prove that defined complementary procedures are beneficial for the patients.</p></abstract><trans-abstract xml:lang="de"><title>Zusammenfassung</title><p>Die Anwendung komplementärmedizinischer Verfahren wird derzeit innerhalb der onkologischen Gemeinschaft stark debattiert, da wissenschaftlich fundierte Untersuchungen/Studien zur Unbedenklichkeit bzw. Wirksamkeit für die meisten Verfahren fehlen. In den vergangenen Jahren sind sowohl die Grundlagenforschung als auch die klinische Evaluation definierter komplementärmedizinischer Konzepte in der Onkologie intensiviert worden, in dem Bestreben, diese Methoden in die evidenzbasierte Medizin zu integrieren. Per Definition können auch wissenschaftlich fundierte komplementärmedizinische Therapien etablierte konventionelle Antikrebstherapien wie Chirurgie, Chemotherapie, Radiotherapie oder Hormontherapie nicht ersetzen. Komplementäre onkologische Ansätze, die ergänzend zu standardisierten Antikrebsthe-rapien empfohlen werden, erheben den Anspruch, diese Therapien optimieren zu können. Eine Vielzahl von Daten aus relevanten klinischen Studien belegen einen Benefit definierter komplementärmedizinischer Maßnahmen für Krebspatienten.</p></trans-abstract><kwd-group><title>Key Words</title><kwd>Breast cancer</kwd><kwd>Complementary medicine</kwd><kwd>Evidence-based medicine</kwd><kwd>Quality of life</kwd><kwd>Quackery</kwd></kwd-group><counts><ref-count count="47"></ref-count><page-count count="5"></page-count></counts></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004776 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 004776 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:2942012
|texte= Evidence-Based Complementary Medicine in Breast Cancer Therapy
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:20877679" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |